HK Stock Market Move | ALI HEALTH (00241) falls more than 3% against the trend, with a mid-term net profit increasing by 64.7% year-on-year to 1.266 billion yuan.
Ali Health (00241) fell against the trend by over 3%, as of the time of publication, the stock dropped by 3.28% to 5.9 Hong Kong dollars, with a turnover of 252 million Hong Kong dollars.
ALI HEALTH (00241) fell against the trend by more than 3%, dropping by 3.28% to HKD 5.9 at the time of writing, with a turnover of HKD 252 million.
On the news front, ALI HEALTH released its mid-term performance for the six months ending September 30,2025. Total revenue was RMB 16.697 billion, a year-on-year increase of 17.0%; net profit was RMB 1.266 billion, a year-on-year increase of 64.7%; and net profit margin increased from 5.4% to 7.6%. Adjusted net profit was RMB 1.356 billion, a year-on-year increase of 38.7%.
Citi released a research report stating that ALI HEALTH raised its full-year revenue growth guidance for 2026 to 10% to 15% in September, and adjusted net profit growth guidance to 20% to 30%. Given the strong growth in adjusted net profit during the period, the bank believes that the market will focus on whether the company's management will adjust its performance guidance accordingly.
Related Articles

GEELY AUTO (00175) will issue a total of 132,500 new shares due to the exercise of subscription rights.

LAI SUN INT'L (00191) and LAI SUN DEV (00488) will be suspended on November 27 for the release of inside information.

FAIRWOOD HOLDINGS LIMITED (00052) will distribute a mid-year dividend of 5 Hong Kong cents per share on December 31st.
GEELY AUTO (00175) will issue a total of 132,500 new shares due to the exercise of subscription rights.

LAI SUN INT'L (00191) and LAI SUN DEV (00488) will be suspended on November 27 for the release of inside information.

FAIRWOOD HOLDINGS LIMITED (00052) will distribute a mid-year dividend of 5 Hong Kong cents per share on December 31st.

RECOMMEND

Hong Kong Stock Buyback Wave Persists, 247 Listed Companies Repurchase Over HKD 150 Billion This Year
27/11/2025

Mingyu Pharmaceutical Files With HKEX: Ongoing Net Losses Since Inception, No Revenue From Commercial Product Sales
27/11/2025

“Affordability Crisis”! Consumer Confidence Falls To Second Lowest Since The Pandemic, U.S. Retail Slumps
27/11/2025


